PMID- 19768242 OWN - NLM STAT- MEDLINE DCOM- 20110202 LR - 20190917 IS - 1677-9487 (Electronic) IS - 0004-2730 (Linking) VI - 53 IP - 5 DP - 2009 Jul TI - [Dietary fibers: current trends and health benefits in the metabolic syndrome and type 2 diabetes]. PG - 509-18 LID - S0004-27302009000500004 [pii] AB - Dietary fiber may contribute to both the prevention and treatment of type 2 diabetes mellitus (T2DM). In epidemiological studies the intake of insoluble fiber, but not the intake of soluble fiber, has been inversely associated with the incidence of T2DM. In contrast, in postprandial studies, meals containing sufficiently quantities of beta-glucan, psyllium, or guar gum have decreased insulin and glucose responses in both healthy individuals and patients with T2DM. Diets enriched sufficiently in soluble fiber may also improve overall glycemic control in T2DM. Insoluble fiber has little effect on postprandial insulin and glucose responses. Fiber increases satiety. In some studies, insoluble fiber has been associated with less weight gain over time. Limited cross-sectional evidence suggests an inverse relationship between intake of cereal fiber and whole-grains and the prevalence of the metabolic syndrome. Although long-term data from trials focusing on specifically dietary fiber are lacking, meeting current recommendations for a minimum fiber intake of 25 g/d based on a diet rich in whole grains, fruits and legumes will probably decrease the risk of obesity, the metabolic syndrome and T2DM. FAU - Mello, Vanessa D de AU - Mello VD AD - School of Public Health and Clinical Nutrition, Department of Clinical Nutrition, University of Kuopio -- P.O. Box 1627, FIN-70211 -- Kuopio, Finland. vanessa.ferreirademello@uku.fi FAU - Laaksonen, David E AU - Laaksonen DE LA - por PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review TT - Fibras na dieta: tendencias atuais e beneficios a saude na sindrome metabolica e no diabetes melito tipo 2. PL - Brazil TA - Arq Bras Endocrinol Metabol JT - Arquivos brasileiros de endocrinologia e metabologia JID - 0403437 RN - 0 (Cathartics) RN - 0 (Dietary Fiber) RN - 0 (Galactans) RN - 0 (Insulin) RN - 0 (Mannans) RN - 0 (Plant Gums) RN - 0 (beta-Glucans) RN - 8063-16-9 (Psyllium) RN - E89I1637KE (guar gum) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Cathartics/administration & dosage MH - Diabetes Mellitus, Type 2/diet therapy/*prevention & control MH - Dietary Fiber/*administration & dosage MH - Epidemiologic Studies MH - Galactans/administration & dosage MH - Glucose/metabolism MH - Humans MH - Insulin/metabolism MH - Mannans/administration & dosage MH - Metabolic Syndrome/diet therapy/*prevention & control MH - Obesity/diet therapy/prevention & control MH - Plant Gums/administration & dosage MH - Postprandial Period MH - Psyllium/administration & dosage MH - Risk Factors MH - beta-Glucans/administration & dosage RF - 69 EDAT- 2009/09/22 06:00 MHDA- 2011/02/03 06:00 CRDT- 2009/09/22 06:00 PHST- 2009/02/28 00:00 [received] PHST- 2009/06/05 00:00 [accepted] PHST- 2009/09/22 06:00 [entrez] PHST- 2009/09/22 06:00 [pubmed] PHST- 2011/02/03 06:00 [medline] AID - S0004-27302009000500004 [pii] AID - 10.1590/s0004-27302009000500004 [doi] PST - ppublish SO - Arq Bras Endocrinol Metabol. 2009 Jul;53(5):509-18. doi: 10.1590/s0004-27302009000500004.